AlphAIAlphAI — Financial news for AI agents
TradingViewMAY 163 min read$CGEN

Compugen Ltd expected to post a loss of 7 cents a share - Earnings Preview

Compugen Ltd is expected to report a loss of 7 cents per share. This earnings preview provides a brief outlook on the company's financial performance.

Original reporting
TradingView · Refinitiv
Published May 16, 2026, 2:09 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 16, 2026, 2:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Compugen Ltd expected to post a loss of 7 cents a share - Earnings Preview — source image
Source · TradingView
Decision brief

The 30-second read

$CGENBearishHigh
01

Why it matters

The earnings forecast indicates challenges ahead, possibly due to R&D setbacks or market conditions.

02

Market read

High relevance for biotech investors; sector sentiment may be affected.

03

What to watch

Potential positive catalysts such as upcoming product approvals or partnerships that could offset earnings concerns.

Timing: Immediate, as earnings release is imminent or has just occurred.

Background

Compugen Ltd operates in the biotech/life sciences sector, with recent developments including pipeline updates and strategic collaborations.

Company-level read

Ticker impact

$CGENBearishHigh confidence
Context

High relevance due to direct impact on company's financials and bearish sentiment.

Expected impact

Moderate decline expected in the near term, approximately 5-8% based on earnings disappointment.

Evidence & confidence

Earnings reports significantly influence stock price, and a predicted loss coupled with bearish sentiment supports a downward movement.

Market effects

Sector

Potential negative sentiment in the biotech/life sciences sector due to earnings outlook.

Regional

Limited, as company-specific news; regional effects minimal.

Global

Low, as it pertains to a single company's earnings.

Counterpoint

What could challenge this read

The company might have already priced in the expected loss, and actual results could be better than forecast, leading to a rebound.

Key entities

  • Company
    Compugen Ltd

    A biotech company focused on immunotherapy and cancer treatment.

Read at source← All news

Related articles

AUG 3
$CGENMed

Compugen Reports Second Quarter 2026 Results

Compugen Ltd. (NASDAQ: CGEN) reported Q2 2026 results and a corporate update. The MAIA-ovarian trial of COM701 is progressing, with median progression-free survival interim data expected in Q1 2027. Partner AstraZeneca presented GEMINI-Hepatobiliary overall survival data for rilvegostomig (median 16.8 months). Cash was about $125.3M, funding operations into 2029. Q2 revenue was ~$2.6M vs ~$1.3M in 2025; net loss ~$7.0M.

prnewswire.com7 min
SEP 17
$DASHMed

DoorDash and Uber eats nationwide delivery services from Costco

Costco partners with DoorDash for nationwide U.S. delivery, expanding from select international markets. Only Costco members linking accounts can use the service. Costco has 81M members and 639 U.S. stores. Instacart has offered delivery for about a decade. Earlier in 2024, Costco also partnered with Uber Eats, which has since expanded nationwide.

sjvsun.com2 min
SEP 17
$LMTMed

LMT Looks 4.5% Undervalued on GF Value™ with Strong Dividend App

Lockheed Martin (LMT) secured a $234.46M contract modification for 16 UH-60M Black Hawk helicopters, raising the total contract value to $356.25M. The company offers a 2.55% dividend yield, a 50% payout ratio, and a 3-year dividend growth rate of 5.4%. LMT's GF Score™ is 80/100, with strengths in profitability and valuation. Institutional activity shows mixed sentiment, with 21 premium gurus holding shares. The stock is trading 4.5% below its GF Value™ of $563.60, at $538.09.

gurufocus.com2 min
SEP 17
$UBERLow

Uber Technologies sells $182.2m of Aurora Innovation stock

Uber sold 29.4 million shares of Aurora Innovation (AUR) for $182.2 million at $6.205 per share, reducing its stake to 157.1 million shares. Aurora's Q2 2026 earnings showed a wider-than-expected loss of $0.14 per share but higher revenue of $2 million. The stock has surged 54% in six months, though it may be overvalued according to InvestingPro analysis.

investing.com2 min